Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |